Abbott Laboratories (ABT) Total Debt Growth (3y) (2012 - 2026)
Powered by 
Analysis
Abbott Laboratories (ABT) Total Debt Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.84 Bn | 178.24 Bn | 7.27 Bn | 24.63% |
| 2 | Intuitive Surgical | 124.46 Bn | 119.24 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.36 Bn | 109.54 Bn | 6.34 Bn | 4.06% |
| 4 | Stryker | 105.10 Bn | 101.62 Bn | 4.50 Bn | 4.89% |
| 5 | Boston Scientific | 66.60 Bn | 66.06 Bn | 3.85 Bn | 11.72% |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.47 Bn | 1.35 Bn | 0.11% |
| 7 | Alcon | 33.92 Bn | 32.46 Bn | 1.68 Bn | 252.76% |
| 8 | Dexcom | 32.31 Bn | 30.36 Bn | 830.00 Mn | - |
| 9 | Steris | 21.10 Bn | 20.62 Bn | 684.20 Mn | -10.56% |
| 10 | Zimmer Biomet Holdings | 18.14 Bn | 17.73 Bn | 1.54 Bn | 9.42% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.63% |
| Mar 31, 2026 | 26.30% |
| Dec 31, 2025 | -12.08% |
| Sep 30, 2025 | -7.62% |
| Jun 30, 2025 | -7.10% |
| Mar 31, 2025 | -8.15% |
| Dec 31, 2024 | -5.99% |
| Sep 30, 2024 | -6.62% |
| Jun 30, 2024 | -7.27% |
| Mar 31, 2024 | -7.52% |
| Dec 31, 2023 | -5.97% |
| Sep 30, 2023 | -6.12% |
| Jun 30, 2023 | -5.05% |
| Mar 31, 2023 | -2.57% |
| Dec 31, 2022 | 1.60% |
| Sep 30, 2022 | -4.92% |
| Jun 30, 2022 | -4.74% |
| Mar 31, 2022 | -3.88% |
| Dec 31, 2021 | -1.64% |
| Sep 30, 2021 | -7.91% |